Showing results (11-20 of 45) with videos related to
Sort By:
Pageof 5
Expert Opinion on Drug Discovery|March 4, 2026
An introduction to GitHub and its significance for AI-Driven drug discoveryAbdallah Abou Hajal, Lana Bustanji, Richard A Bryce, et al.Drug Design, Development and Therapy|October 21, 2016
Druggability analysis and classification of protein tyrosine phosphatase active sitesMohammad A Ghattas, Noor Raslan, Asil Sadeq, et al.Journal of Computer-Aided Molecular Design|March 12, 2024
Molecular dynamics simulations as a guide for modulating small molecule aggregationAzam Nesabi, Jas Kalayan, Sara Al-Rawashdeh, et al.Scientific Reports|May 13, 2022
Structure-based assessment and druggability classification of protein-protein interaction sitesLara Alzyoud, Richard A Bryce, Mohammad Al Sorkhy, et al.European Journal of Medicinal Chemistry|May 14, 2017
Antibacterial activity and mechanism of action of the benzazole acrylonitrile-based compounds: In vitro, spectroscopic, and docking studiesShaikha S AlNeyadi, Alaa A Salem, Mohammad A Ghattas, et al.Drug Design, Development and Therapy|November 23, 2018
Identification of new inhibitors of Mdm2-p53 interaction via pharmacophore and structure-based virtual screeningNoor Atatreh, Mohammad A Ghattas, Sanaa K Bardaweel, et al.Chemmedchem|October 24, 2017
Comparative Molecular Dynamics Simulation of Aggregating and Non-Aggregating Inhibitor Solutions: Understanding the Molecular Basis of PromiscuityMohammad A Ghattas, Richard A Bryce, Sara Al Rawashdah, et al.Journal of Chemical Information and Modeling|June 26, 2024
Boosting the Accuracy and Chemical Space Coverage of the Detection of Small Colloidal Aggregating Molecules Using the BAD Molecule FilterAbdallah Abou Hajal, Richard A Bryce, Boulbaba Ben Amor, et al.Journal of Enzyme Inhibition and Medicinal Chemistry|July 27, 2019
Discovery of new butyrylcholinesterase inhibitors via structure-based virtual screeningNoor Atatreh, Sara Al Rawashdah, Shaikha S Al Neyadi, et al.Chemical Biology & Drug Design|May 8, 2019
Structure-based drug design and in vitro testing reveal new inhibitors of enoyl-acyl carrier protein reductasesMohammad A Ghattas, Nermin A Eissa, Francesca Tessaro, et al.Pageof 5